Financial Metrics

BDX BECTON DICKINSON & CO

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.56	—	USD/shares	10-Q	2017-05-02
Quarterly	2016-06-30	1.8	+15.4%	USD/shares	10-Q	2017-08-03
Quarterly	2016-12-31	2.58	+43.3%	USD/shares	10-Q	2018-02-06
Quarterly	2017-03-31	1.58	-38.8%	USD/shares	10-Q	2018-05-03
Quarterly	2017-06-30	-0.75	-147.5%	USD/shares	10-Q	2018-08-02
Quarterly	2017-12-31	-0.76	-1.3%	USD/shares	10-Q	2019-02-05
Quarterly	2018-03-31	-0.19	+75.0%	USD/shares	10-Q	2019-05-09
Quarterly	2018-06-30	2.03	+1168.4%	USD/shares	10-Q	2019-08-06
Quarterly	2018-12-31	2.05	+1.0%	USD/shares	10-Q	2020-02-06
Quarterly	2019-03-31	-0.07	-103.4%	USD/shares	10-Q	2020-05-07
Quarterly	2019-06-30	1.51	+2257.1%	USD/shares	10-Q	2020-08-06
Quarterly	2019-12-31	0.87	-42.4%	USD/shares	10-Q	2021-02-04
Quarterly	2020-03-31	0.53	-39.1%	USD/shares	10-Q	2021-05-06
Quarterly	2020-06-30	0.97	+83.0%	USD/shares	10-Q	2021-08-05
Quarterly	2020-12-31	3.35	+245.4%	USD/shares	10-Q	2022-02-03
Quarterly	2021-03-31	0.94	-71.9%	USD/shares	10-Q	2022-05-05
Quarterly	2021-06-30	1.72	+83.0%	USD/shares	10-Q	2022-08-04
Quarterly	2021-12-31	2.28	+32.6%	USD/shares	10-Q	2023-02-02
Quarterly	2022-03-31	1.5	-34.2%	USD/shares	10-Q	2023-05-04
Quarterly	2022-06-30	1.18	-21.3%	USD/shares	10-Q	2023-08-03
Quarterly	2022-12-31	1.7	+44.1%	USD/shares	10-Q	2024-02-01
Quarterly	2023-03-31	1.53	-10.0%	USD/shares	10-Q	2024-05-02
Quarterly	2023-06-30	1.36	-11.1%	USD/shares	10-Q	2024-08-01
Quarterly	2023-12-31	0.96	-29.4%	USD/shares	10-Q	2025-02-06
Quarterly	2024-03-31	1.85	+92.7%	USD/shares	10-Q	2025-05-01
Quarterly	2024-06-30	1.68	-9.2%	USD/shares	10-Q	2025-08-07
Quarterly	2024-12-31	1.04	-38.1%	USD/shares	10-Q	2026-02-09
Quarterly	2025-03-31	1.07	+2.9%	USD/shares	10-Q	2025-05-01
Quarterly	2025-06-30	2.0	+86.9%	USD/shares	10-Q	2025-08-07
Quarterly	2025-12-31	1.34	-33.0%	USD/shares	10-Q	2026-02-09
Annual	2016-12-31	2.58	—	USD/shares	10-K	2018-11-21
Annual	2017-12-31	-0.76	-129.5%	USD/shares	10-K	2019-11-27
Annual	2018-12-31	2.05	+369.7%	USD/shares	10-K	2020-11-25
Annual	2019-12-31	0.87	-57.6%	USD/shares	10-K	2020-11-25
Annual	2020-09-30	2.71	+211.5%	USD/shares	10-K	2022-11-22
Annual	2021-09-30	6.85	+152.8%	USD/shares	10-K	2023-11-21
Annual	2022-09-30	5.88	-14.2%	USD/shares	10-K	2024-11-27
Annual	2023-09-30	4.94	-16.0%	USD/shares	10-K	2025-11-25
Annual	2024-09-30	5.86	+18.6%	USD/shares	10-K	2025-11-25
Annual	2025-09-30	5.82	-0.7%	USD/shares	10-K	2025-11-25

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	10864000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	10561000000.0	-2.8%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	10550000000.0	-0.1%	USD	10-Q	2017-08-03
Quarterly	2016-12-31	9043000000.0	-14.3%	USD	10-Q	2017-02-02
Quarterly	2017-03-31	9082000000.0	+0.4%	USD	10-Q	2017-05-02
Quarterly	2017-06-30	18563000000.0	+104.4%	USD	10-Q	2017-08-03
Quarterly	2017-09-30	18667000000.0	+0.6%	USD	10-Q	2018-08-02
Quarterly	2017-12-31	22095000000.0	+18.4%	USD	10-Q	2018-02-06
Quarterly	2018-03-31	22589000000.0	+2.2%	USD	10-Q	2018-05-03
Quarterly	2018-06-30	20350000000.0	-9.9%	USD	10-Q	2018-08-02
Quarterly	2018-09-30	18894000000.0	-7.2%	USD	10-Q	2019-08-06
Quarterly	2018-12-31	17817000000.0	-5.7%	USD	10-Q	2019-02-05
Quarterly	2019-03-31	17556000000.0	-1.5%	USD	10-Q	2019-05-09
Quarterly	2019-06-30	18016000000.0	+2.6%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	18081000000.0	+0.4%	USD	10-Q	2020-08-06
Quarterly	2019-12-31	16949000000.0	-6.3%	USD	10-Q	2020-02-06
Quarterly	2020-03-31	16809000000.0	-0.8%	USD	10-Q	2020-05-07
Quarterly	2020-06-30	17090000000.0	+1.7%	USD	10-Q	2020-08-06
Quarterly	2020-09-30	17224000000.0	+0.8%	USD	10-Q	2021-08-05
Quarterly	2020-12-31	16082000000.0	-6.6%	USD	10-Q	2021-02-04
Quarterly	2021-03-31	17718000000.0	+10.2%	USD	10-Q	2021-05-06
Quarterly	2021-06-30	15700000000.0	-11.4%	USD	10-Q	2021-08-05
Quarterly	2021-09-30	17110000000.0	+9.0%	USD	10-Q	2022-08-04
Quarterly	2021-12-31	16360000000.0	-4.4%	USD	10-Q	2022-02-03
Quarterly	2022-03-31	17584000000.0	+7.5%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	14683000000.0	-16.5%	USD	10-Q	2022-08-04
Quarterly	2022-09-30	13886000000.0	-5.4%	USD	10-Q	2023-08-03
Quarterly	2022-12-31	14268000000.0	+2.8%	USD	10-Q	2023-02-02
Quarterly	2023-03-31	16010000000.0	+12.2%	USD	10-Q	2023-05-04
Quarterly	2023-06-30	14926000000.0	-6.8%	USD	10-Q	2023-08-03
Quarterly	2023-09-30	14738000000.0	-1.3%	USD	10-Q	2024-08-01
Quarterly	2023-12-31	14094000000.0	-4.4%	USD	10-Q	2024-02-01
Quarterly	2024-03-31	15995000000.0	+13.5%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	18131000000.0	+13.4%	USD	10-Q	2024-08-01
Quarterly	2024-09-30	17940000000.0	-1.1%	USD	10-Q	2025-08-07
Quarterly	2024-12-31	17440000000.0	-2.8%	USD	10-Q	2025-02-06
Quarterly	2025-03-31	17666000000.0	+1.3%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	17531000000.0	-0.8%	USD	10-Q	2025-08-07
Quarterly	2025-09-30	17621000000.0	+0.5%	USD	10-Q	2026-02-09
Quarterly	2025-12-31	16916000000.0	-4.0%	USD	10-Q	2026-02-09
Annual	2016-09-30	10550000000.0	—	USD	10-K	2017-11-22
Annual	2017-09-30	18667000000.0	+76.9%	USD	10-K	2018-11-21
Annual	2018-09-30	18894000000.0	+1.2%	USD	10-K	2019-11-27
Annual	2019-09-30	18081000000.0	-4.3%	USD	10-K	2020-11-25
Annual	2020-09-30	17224000000.0	-4.7%	USD	10-K	2021-11-24
Annual	2021-09-30	17110000000.0	-0.7%	USD	10-K	2022-11-22
Annual	2022-09-30	13886000000.0	-18.8%	USD	10-K	2023-11-21
Annual	2023-09-30	14738000000.0	+6.1%	USD	10-K	2024-11-27
Annual	2024-09-30	17940000000.0	+21.7%	USD	10-K	2025-11-25
Annual	2025-09-30	17621000000.0	-1.8%	USD	10-K	2025-11-25

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	258000000.0	—	USD	10-Q	2017-05-02
Quarterly	2016-06-30	405000000.0	+57.0%	USD	10-Q	2017-08-03
Quarterly	2016-12-31	112000000.0	-72.3%	USD	10-Q	2018-02-06
Quarterly	2017-03-31	272000000.0	+142.9%	USD	10-Q	2018-05-03
Quarterly	2017-06-30	467000000.0	+71.7%	USD	10-Q	2018-08-02
Quarterly	2017-12-31	178000000.0	-61.9%	USD	10-Q	2019-02-05
Quarterly	2018-03-31	391000000.0	+119.7%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	588000000.0	+50.4%	USD	10-Q	2019-08-06
Quarterly	2018-12-31	167000000.0	-71.6%	USD	10-Q	2020-02-06
Quarterly	2019-03-31	362000000.0	+116.8%	USD	10-Q	2020-05-07
Quarterly	2019-06-30	599000000.0	+65.5%	USD	10-Q	2020-08-06
Quarterly	2019-12-31	173000000.0	-71.1%	USD	10-Q	2021-02-04
Quarterly	2020-03-31	395000000.0	+128.3%	USD	10-Q	2021-05-06
Quarterly	2020-06-30	597000000.0	+51.1%	USD	10-Q	2021-08-05
Quarterly	2020-12-31	246000000.0	-58.8%	USD	10-Q	2022-02-03
Quarterly	2021-03-31	499000000.0	+102.8%	USD	10-Q	2022-05-05
Quarterly	2021-06-30	742000000.0	+48.7%	USD	10-Q	2022-08-04
Quarterly	2021-12-31	183000000.0	-75.3%	USD	10-Q	2023-02-02
Quarterly	2022-03-31	405000000.0	+121.3%	USD	10-Q	2023-05-04
Quarterly	2022-06-30	658000000.0	+62.5%	USD	10-Q	2023-08-03
Quarterly	2022-12-31	208000000.0	-68.4%	USD	10-Q	2024-02-01
Quarterly	2023-03-31	389000000.0	+87.0%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	580000000.0	+49.1%	USD	10-Q	2024-08-01
Quarterly	2023-12-31	116000000.0	-80.0%	USD	10-Q	2025-02-06
Quarterly	2024-03-31	250000000.0	+115.5%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	429000000.0	+71.6%	USD	10-Q	2025-08-07
Quarterly	2024-12-31	105000000.0	-75.5%	USD	10-Q	2026-02-09
Quarterly	2025-03-31	234000000.0	+122.9%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	408000000.0	+74.4%	USD	10-Q	2025-08-07
Quarterly	2025-12-31	108000000.0	-73.5%	USD	10-Q	2026-02-09
Annual	2016-09-30	693000000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	727000000.0	+4.9%	USD	10-K	2019-11-27
Annual	2018-09-30	895000000.0	+23.1%	USD	10-K	2020-11-25
Annual	2019-09-30	957000000.0	+6.9%	USD	10-K	2021-11-24
Annual	2020-09-30	769000000.0	-19.6%	USD	10-K	2022-11-22
Annual	2021-09-30	1194000000.0	+55.3%	USD	10-K	2023-11-21
Annual	2022-09-30	973000000.0	-18.5%	USD	10-K	2024-11-27
Annual	2023-09-30	874000000.0	-10.2%	USD	10-K	2025-11-25
Annual	2024-09-30	725000000.0	-17.0%	USD	10-K	2025-11-25
Annual	2025-09-30	760000000.0	+4.8%	USD	10-K	2025-11-25

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	216538000.0	—	shares	10-Q	2017-05-02
Quarterly	2016-06-30	217372000.0	+0.4%	shares	10-Q	2017-08-03
Quarterly	2016-12-31	217739000.0	+0.2%	shares	10-Q	2018-02-06
Quarterly	2017-03-31	217866000.0	+0.1%	shares	10-Q	2018-05-03
Quarterly	2017-06-30	220807000.0	+1.3%	shares	10-Q	2018-08-02
Quarterly	2017-12-31	230038000.0	+4.2%	shares	10-Q	2019-02-05
Quarterly	2018-03-31	267341000.0	+16.2%	shares	10-Q	2019-05-09
Quarterly	2018-06-30	273925000.0	+2.5%	shares	10-Q	2019-08-06
Quarterly	2018-12-31	274256000.0	+0.1%	shares	10-Q	2020-02-06
Quarterly	2019-03-31	269882000.0	-1.6%	shares	10-Q	2020-05-07
Quarterly	2019-06-30	274336000.0	+1.7%	shares	10-Q	2020-08-06
Quarterly	2019-12-31	274952000.0	+0.2%	shares	10-Q	2021-02-04
Quarterly	2020-03-31	275037000.0	+0.0%	shares	10-Q	2021-05-06
Quarterly	2020-06-30	285148000.0	+3.7%	shares	10-Q	2021-08-05
Quarterly	2020-12-31	293112000.0	+2.8%	shares	10-Q	2022-02-03
Quarterly	2021-03-31	293547000.0	+0.1%	shares	10-Q	2022-05-05
Quarterly	2021-06-30	291897000.0	-0.6%	shares	10-Q	2022-08-04
Quarterly	2021-12-31	286723000.0	-1.8%	shares	10-Q	2023-02-02
Quarterly	2022-03-31	287299000.0	+0.2%	shares	10-Q	2023-05-04
Quarterly	2022-06-30	287297000.0	-0.0%	shares	10-Q	2023-08-03
Quarterly	2022-12-31	285340000.0	-0.7%	shares	10-Q	2024-02-01
Quarterly	2023-03-31	285645000.0	+0.1%	shares	10-Q	2024-05-02
Quarterly	2023-06-30	287944000.0	+0.8%	shares	10-Q	2024-08-01
Quarterly	2023-12-31	291398000.0	+1.2%	shares	10-Q	2025-02-06
Quarterly	2024-03-31	290344000.0	-0.4%	shares	10-Q	2025-05-01
Quarterly	2024-06-30	290253000.0	-0.0%	shares	10-Q	2025-08-07
Quarterly	2024-12-31	290389000.0	+0.0%	shares	10-Q	2026-02-09
Quarterly	2025-03-31	287737000.0	-0.9%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	287223000.0	-0.2%	shares	10-Q	2025-08-07
Quarterly	2025-12-31	285845000.0	-0.5%	shares	10-Q	2026-02-09
Annual	2016-09-30	217536000.0	—	shares	10-K	2018-11-21
Annual	2017-09-30	223588000.0	+2.8%	shares	10-K	2019-11-27
Annual	2018-09-30	264621000.0	+18.4%	shares	10-K	2020-11-25
Annual	2019-09-30	274775000.0	+3.8%	shares	10-K	2021-11-24
Annual	2020-09-30	282402000.0	+2.8%	shares	10-K	2022-11-22
Annual	2021-09-30	292089000.0	+3.4%	shares	10-K	2023-11-21
Annual	2022-09-30	287364000.0	-1.6%	shares	10-K	2024-11-27
Annual	2023-09-30	288392000.0	+0.4%	shares	10-K	2025-11-25
Annual	2024-09-30	291009000.0	+0.9%	shares	10-K	2025-11-25
Annual	2025-09-30	288509000.0	-0.9%	shares	10-K	2025-11-25

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

17,621,000,000

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

8,313,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0441	—	ratio	10-Q	2017-05-02
Quarterly	2016-06-30	0.0485	+10.1%	ratio	10-Q	2017-08-03
Quarterly	2016-12-31	0.0741	+52.7%	ratio	10-Q	2018-02-06
Quarterly	2017-03-31	0.0432	-41.7%	ratio	10-Q	2018-05-03
Quarterly	2017-06-30	-0.0105	-124.3%	ratio	10-Q	2018-08-02
Quarterly	2017-12-31	-0.0064	+39.0%	ratio	10-Q	2019-02-05
Quarterly	2018-03-31	-0.0006	+91.1%	ratio	10-Q	2019-05-09
Quarterly	2018-06-30	0.0278	+5002.5%	ratio	10-Q	2019-08-06
Quarterly	2018-12-31	0.0280	+0.6%	ratio	10-Q	2020-02-06
Quarterly	2019-03-31	0.0009	-96.6%	ratio	10-Q	2020-05-07
Quarterly	2019-06-30	0.0210	+2135.3%	ratio	10-Q	2020-08-06
Quarterly	2019-12-31	0.0131	-37.5%	ratio	10-Q	2021-02-04
Quarterly	2020-03-31	0.0087	-33.4%	ratio	10-Q	2021-05-06
Quarterly	2020-06-30	0.0119	+36.3%	ratio	10-Q	2021-08-05
Quarterly	2020-12-31	0.0407	+241.6%	ratio	10-Q	2022-02-03
Quarterly	2021-03-31	0.0120	-70.4%	ratio	10-Q	2022-05-05
Quarterly	2021-06-30	0.0218	+80.6%	ratio	10-Q	2022-08-04
Quarterly	2021-12-31	0.0280	+28.8%	ratio	10-Q	2023-02-02
Quarterly	2022-03-31	0.0185	-33.9%	ratio	10-Q	2023-05-04
Quarterly	2022-06-30	0.0141	-23.7%	ratio	10-Q	2023-08-03
Quarterly	2022-12-31	0.0200	+41.5%	ratio	10-Q	2024-02-01
Quarterly	2023-03-31	0.0179	-10.4%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	0.0157	-12.4%	ratio	10-Q	2024-08-01
Quarterly	2023-12-31	0.0111	-29.3%	ratio	10-Q	2025-02-06
Quarterly	2024-03-31	0.0209	+88.8%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	0.0188	-10.1%	ratio	10-Q	2025-08-07
Quarterly	2024-12-31	0.0120	-36.1%	ratio	10-Q	2026-02-09
Quarterly	2025-03-31	0.0122	+1.5%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.0225	+84.7%	ratio	10-Q	2025-08-07
Quarterly	2025-12-31	0.0151	-32.9%	ratio	10-Q	2026-02-09
Annual	2020-09-30	0.0368	—	ratio	10-K	2022-11-22
Annual	2021-09-30	0.0884	+140.2%	ratio	10-K	2023-11-21
Annual	2022-09-30	0.0704	-20.4%	ratio	10-K	2024-11-27
Annual	2023-09-30	0.0575	-18.2%	ratio	10-K	2025-11-25
Annual	2024-09-30	0.0659	+14.5%	ratio	10-K	2025-11-25
Annual	2025-09-30	0.0661	+0.4%	ratio	10-K	2025-11-25

8-K Material Event Details

85 filings · 193 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

586 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-06	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	1,146	$0.00	$0	23,966
2026-03-26	Feld Michael	EVP, Chief Revenue Officer	Open-market sell S	Common Stock	75	$156.83	$11,762	21,233
2026-03-16	Minnix Lanesha	EVP and General Counsel	Equity grant / award A	Common Stock	7,492	$0.00	$0	7,492
2026-03-02	Roque Vitor	Interim CFO	Equity grant / award A	Common Stock	931	$0.00	$0	6,510
2026-02-26	Feld Michael	EVP, Chief Revenue Officer	Open-market sell S	Common Stock	75	$181.84	$13,638	21,308
2026-02-18	SCOTT BERTRAM L	Dir	Open-market sell S	Common Stock	953	$182.61	$174,027	36,763
2026-02-09	BECTON DICKINSON & CO	—	Other disposed transaction J	Common Stock, par value $0.01 per share	284,771,350	—	—	0
2026-02-04	Huffines Robert Luther	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	100	$201.91	$20,191	100
2026-01-27	Henderson Jeffrey William	Dir	Equity grant / award A	Common Stock	1,098	$0.00	$0	9,143
2026-01-26	Feld Michael	EVP, CRO & Pres. Life Sciences	Open-market sell S	Common Stock	75	$202.73	$15,205	16,431
2026-01-21	Spikner Pamela L.	SVP Controller & CAO	Other disposed transaction F	Common Stock	84	$0.00	$0	1,832
2026-01-15	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Exercise / conversion M · derivative	Stock Appreciation Rights	3,054	$0.00	$0	0
2026-01-15	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Open-market sell S	Common Stock	1,010	$206.54	$208,605	12,095
2026-01-15	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Open-market sell S	Common Stock	600	$209.00	$125,400	13,105
2026-01-15	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Other disposed transaction D	Common Stock	2,454	$209.00	$512,886	13,705
2026-01-15	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Exercise / conversion M	Common Stock	3,054	$167.91	$512,797	16,159
2026-01-03	Shan David	EVP and Chief ISC Officer	Other disposed transaction F	Common Stock	44	$0.00	$0	8,926
2025-12-26	Feld Michael	EVP, CRO & Pres. Life Sciences	Open-market sell S	Common Stock	74	$196.08	$14,510	16,506
2025-12-17	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	Open-market sell S	Common Stock	629	$196.03	$123,303	13,105
2025-12-01	Feld Michael	EVP, CRO & Pres. Life Sciences	Open-market sell S	Common Stock	75	$193.36	$14,502	16,580
2025-11-26	Mocherla Pavan Kumar	EVP & President, Greater Asia	Equity grant / award A	Common Stock	708	$0.00	$0	5,763
2025-11-26	Mocherla Pavan Kumar	EVP & President, Greater Asia	Equity grant / award A	Common Stock	2,208	$0.00	$0	5,055
2025-11-07	SCOTT BERTRAM L	Dir	Open-market sell S	Common Stock	217	$176.58	$38,318	35,816
2025-11-04	Byington Carrie L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	34	$178.71	$6,076	1,675
2025-10-27	Feld Michael	EVP & President, Life Sciences	Open-market sell S	Common Stock	57	$186.01	$10,603	8,245
2025-09-26	Feld Michael	EVP & President, Life Sciences	Open-market sell S	Common Stock	58	$181.03	$10,500	8,302
2025-09-10	Fraser Claire	Dir	Open-market sell S	Common Stock	917	$187.50	$171,938	22,226
2025-09-01	DelOrefice Christopher	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	278	$0.00	$0	21,221
2025-08-22	Feld Michael	EVP & President, Life Sciences	Open-market sell S	Common Stock	57	$197.99	$11,285	8,360
2025-08-20	Feld Michael	EVP & President, Life Sciences	Other disposed transaction F	Common Stock	773	$0.00	$0	8,417
2025-08-11	HAYES GREGORY	Dir	Open-market buy P	Common Stock	5,250	$191.57	$1,005,742	6,046
2025-08-08	Fraser Claire	Dir	Open-market sell S	Common Stock	863	$192.30	$165,955	23,143
2025-08-07	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	168	$178.25	$29,946	11,089
2025-07-18	Garrison Michael David	EVP & President, Medical	Exercise / conversion M · derivative	Stock Appreciation Rights	6,360	$0.00	$0	0
2025-07-18	Garrison Michael David	EVP & President, Medical	Open-market sell S	Common Stock	1	$181.50	$182	4,887
2025-07-18	Garrison Michael David	EVP & President, Medical	Open-market sell S	Common Stock	1,184	$180.29	$213,463	4,888
2025-07-18	Garrison Michael David	EVP & President, Medical	Other disposed transaction D	Common Stock	5,175	$180.29	$933,001	6,072
2025-07-18	Garrison Michael David	EVP & President, Medical	Exercise / conversion M	Common Stock	6,360	$147.68	$939,245	11,247
2025-07-02	Muhsin Bilal	EVP & President Connected Care	Equity grant / award A	Common Stock	12,221	$0.00	$0	12,221
2025-06-02	Shan David	EVP and Chief ISC Officer	Open-market sell S	Common Stock	1,166	$171.19	$199,608	4,575
2025-05-06	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	145	$207.09	$30,028	10,855
2025-04-09	Garrison Michael David	EVP & President, Medical	Open-market sell S	Common Stock	479	$197.28	$94,497	4,887
2025-04-04	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	1,886	$0.00	$0	13,528
2025-03-26	HAYES GREGORY	Dir	Equity grant / award A	Common Stock	796	$0.00	$0	796
2025-03-18	Byrd Richard	EVP & President Interventional	Open-market sell S	Common Stock	459	$230.00	$105,570	6,952
2025-03-12	Byrd Richard	EVP & President Interventional	Open-market sell S	Common Stock	1,940	$224.91	$436,325	7,411
2025-03-01	Garrison Michael David	EVP & President Medical	Other disposed transaction F	Common Stock	178	$0.00	$0	5,366
2025-02-12	SCOTT BERTRAM L	Dir	Open-market sell S	Common Stock	700	$227.99	$159,593	36,033
2025-02-10	Henderson Jeffrey William	Dir	Open-market buy P	Common Stock	1,500	$233.62	$350,430	8,015
2025-02-06	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	222	$247.60	$54,967	10,662
2025-01-28	Brown William M	Dir	Equity grant / award A	Common Stock	930	$0.00	$0	3,486
2025-01-21	Shan David	EVP and Chief ISC Officer	Open-market sell S	Common Stock	500	$240.00	$120,000	5,741
2025-01-17	Garrison Michael David	EVP & President, Medical	Open-market sell S	Common Stock	597	$236.51	$141,196	5,544
2025-01-07	Neal Shana Carol	EVP and Chief People Officer	Open-market sell S	Common Stock	788	$235.00	$185,180	16,201
2025-01-03	Shan David	EVP and Chief ISC Officer	Other disposed transaction F	Common Stock	44	$0.00	$0	6,241
2024-12-19	Garrison Michael David	EVP & President, Medical	Open-market sell S	Common Stock	2,838	$223.33	$633,811	6,141
2024-12-09	Goette Roland	EVP and President, EMEA	Open-market sell S	Common Stock	638	$219.03	$139,741	14,217
2024-12-06	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	6,339	$0.00	$0	0
2024-12-06	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	6,995	$0.00	$0	0
2024-12-06	Goette Roland	EVP and President, EMEA	Other disposed transaction D	Common Stock	9,490	$221.01	$2,097,385	14,855
2024-12-06	Goette Roland	EVP and President, EMEA	Open-market sell S	Common Stock	4,483	$221.01	$990,788	24,345
2024-12-06	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	6,339	$167.91	$1,064,381	28,828
2024-12-06	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	6,995	$147.68	$1,033,022	22,489
2024-12-05	Shan David	EVP and Chief ISC Officer	Open-market sell S	Common Stock	1,500	$220.25	$330,375	6,285
2024-11-26	Mocherla Pavan Kumar	EVP & President Greater Asia	Equity grant / award A · derivative	Stock Appreciation Rights	3,426	$0.00	$0	3,426
2024-11-26	Mocherla Pavan Kumar	EVP & President Greater Asia	Other disposed transaction F	Common Stock	20	$0.00	$0	2,852
2024-11-26	Mocherla Pavan Kumar	EVP & President Greater Asia	Equity grant / award A	Common Stock	180	$0.00	$0	2,872
2024-11-26	Mocherla Pavan Kumar	EVP & President Greater Asia	Equity grant / award A	Common Stock	875	$0.00	$0	2,692
2024-11-26	Mocherla Pavan Kumar	EVP & President, Greater Asia	Other disposed transaction F	Common Stock	25	$0.00	$0	2,847
2024-11-21	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M · derivative	Rights to Common Stock Under Deferred Compensation Plan	111	$0.00	$0	337
2024-11-21	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	32	$0.00	$0	16,989
2024-11-21	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M	Common Stock	111	$0.00	$0	17,021
2024-11-05	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	128	$233.59	$29,900	10,392
2024-09-07	DelOrefice Christopher	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	466	$0.00	$0	12,792
2024-09-01	Byrd Richard	EVP & President Interventional	Other disposed transaction F	Common Stock	216	$0.00	$0	6,060
2024-08-20	Feld Michael	EVP & President, Life Sciences	Equity grant / award A	Common Stock	6,637	$0.00	$0	6,637
2024-08-14	Goette Roland	EVP and President EMEA	Exercise / conversion M · derivative	Stock Appreciated Rights	5,295	$0.00	$0	0
2024-08-14	Goette Roland	EVP and President EMEA	Other disposed transaction D	Common Stock	4,018	$234.08	$940,533	12,585
2024-08-14	Goette Roland	EVP and President EMEA	Exercise / conversion M	Common Stock	5,295	$132.54	$701,799	16,603
2024-07-31	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	124	$241.05	$29,890	10,224
2024-07-01	Spoerel Thomas J	SVPController & Chief Acct Off	Other disposed transaction F	Common Stock	48	$0.00	$0	1,928
2024-06-10	Spoerel Thomas J	SVP,Controller&Chief Acct Off	Open-market sell S	Common Stock	300	$239.31	$71,793	1,976
2024-05-15	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	1,100	$237.46	$261,206	11,308
2024-05-15	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	1,400	$236.99	$331,786	12,408
2024-05-15	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	800	$235.29	$188,232	13,808
2024-05-13	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	28	$237.90	$6,661	14,608
2024-05-13	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	1,572	$237.14	$372,784	14,636
2024-05-13	Goette Roland	EVP and President EMEA	Open-market sell S	Common Stock	1,700	$236.28	$401,676	16,208
2024-05-03	Byington Carrie L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	129	$233.44	$30,114	1,162
2024-04-30	Garrison Michael David	EVP & President Medical	Open-market sell S	Common Stock	1,715	$232.81	$399,269	5,381
2024-04-04	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	1,921	$0.00	$0	16,389
2024-03-14	Spoerel Thomas J	SVP,Controller&Chief Acct Off	Open-market sell S	Common Stock	282	$238.29	$67,198	2,276
2024-03-01	Garrison Michael David	EVP & President Medical	Other disposed transaction F	Common Stock	178	$0.00	$0	7,096
2024-02-05	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock UnderBD Deferred Compensation Plan	230	$238.80	$54,924	9,891
2024-02-05	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	126	$238.80	$30,089	9,787
2024-01-23	Waldstreicher Joanne	Dir	Equity grant / award A	Common Stock	900	$0.00	$0	1,323
2024-01-03	Shan David	EVP and Chief ISC Officer	Other disposed transaction F	Common Stock	44	$0.00	$0	5,693
2023-12-11	Garrison Michael David	EVP & President Medical	Open-market sell S	Common Stock	1,239	$232.46	$288,018	7,274
2023-11-28	Byrd Richard	EVP & President Interventional	Open-market sell S	Common Stock	2,156	$238.47	$514,141	4,120
2023-11-26	Spoerel Thomas J	SVPController & Chief Acct Off	Equity grant / award A · derivative	Stock Appreciation Rights	2,764	$0.00	$0	2,674
2023-11-26	Spoerel Thomas J	SVPController & Chief Acct Off	Other disposed transaction F	Common Stock	365	$0.00	$0	2,594
2023-11-26	Spoerel Thomas J	SVPController & Chief Acct Off	Equity grant / award A	Common Stock	757	$0.00	$0	2,959
2023-11-26	Spoerel Thomas J	SVPController & Chief Acct Off	Equity grant / award A	Common Stock	375	$0.00	$0	2,202
2023-11-20	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M · derivative	Rights to Common Stock Under Deferred Compensation Plan	110	$0.00	$0	448
2023-11-20	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	31	$0.00	$0	16,910
2023-11-20	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M	Common Stock	110	$0.00	$0	16,941
2023-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	3,544	$0.00	$0	0
2023-11-16	Goette Roland	EVP and President, EMEA	Other disposed transaction D	Common Stock	1,751	$235.07	$411,608	15,413
2023-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	3,544	$107.12	$379,633	17,164
2023-11-16	Goette Roland	EVP and President, EMEA	Other disposed transaction D	Common Stock	2,233	$235.07	$524,911	14,931
2023-11-03	Byington Carrie L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	118	$252.78	$29,828	910
2023-09-07	DelOrefice Christopher	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	601	$0.00	$0	10,999
2023-09-05	Byrd Richard	EVP & President Interventional	Open-market sell S	Common Stock	459	$274.48	$125,986	3,444
2023-09-01	Byrd Richard	EVP & President Interventional	Other disposed transaction F	Common Stock	216	$0.00	$0	3,903
2023-08-28	Fraser Claire	Dir	Open-market sell S	Common Stock	848	$281.66	$238,848	21,608
2023-08-11	Hickey David	EVP & President, Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	3,883	$0.00	$0	0
2023-08-11	Hickey David	EVP & President, Life Sciences	Open-market sell S	Common Stock	2,974	$277.85	$826,326	4,199
2023-08-11	Hickey David	EVP & President, Life Sciences	Other disposed transaction D	Common Stock	1,857	$277.85	$515,967	7,173
2023-08-11	Hickey David	EVP & President, Life Sciences	Exercise / conversion M	Common Stock	3,883	$132.54	$514,653	9,030
2023-08-08	Garrison Michael David	EVP & President Medical	Open-market sell S	Common Stock	1,300	$277.13	$360,269	5,157
2023-08-02	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	108	$276.23	$29,833	9,441
2023-07-24	Waldstreicher Joanne	Dir	Equity grant / award A	Common Stock	419	$0.00	$0	419
2023-07-01	Spoerel Thomas J	VP Controller & Chief Acct Off	Equity grant / award A	Common Stock	47	$0.00	$0	1,827
2023-05-05	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	118	$253.66	$29,932	9,270
2023-05-01	Quinn Michelle	EVP and General Counsel	Other disposed transaction F	Common Stock	99	$0.00	$0	3,280
2023-04-04	Neal Shana Carol	Chief Human Resources Officer	Equity grant / award A	Common Stock	8,229	$0.00	$0	16,909
2023-04-04	Neal Shana Carol	Chief Human Resources Officer	Other disposed transaction F	Common Stock	731	$0.00	$0	8,680
2023-03-02	Ezell Antoine C	EVP, President NA & CMO	Other disposed transaction F	Common Stock	650	$0.00	$0	7,187
2023-03-01	Spoerel Thomas J	SVP,Controller&Chief Acct Off	Other disposed transaction F	Common Stock	35	$0.00	$0	1,874
2023-02-03	Byrd Richard	EVP & President Interventional	Open-market sell S	Common Stock	1,421	$248.60	$353,261	4,119
2023-02-02	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	205	$252.22	$51,705	9,086
2023-01-24	SCOTT BERTRAM L	Dir	Equity grant / award A	Common Stock	848	$0.00	$0	33,779
2023-01-24	Jones Christopher Ian Montague	Dir	Equity grant / award A	Common Stock	848	$0.00	$0	20,198
2022-12-21	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	19	$0.00	$0	9,251
2022-12-13	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	40	$0.00	$0	9,270
2022-11-26	Khichi Samrat S.	EVP & General Counsel	Equity grant / award A · derivative	Stock Appreciation Rights	12,484	$0.00	$0	12,484
2022-11-26	Khichi Samrat S.	EVP & General Counsel	Other disposed transaction F	Common Stock	1,908	$0.00	$0	9,310
2022-11-26	Khichi Samrat S.	EVP & General Counsel	Equity grant / award A	Common Stock	1,956	$0.00	$0	11,218
2022-11-26	Khichi Samrat S.	EVP & General Counsel	Equity grant / award A	Common Stock	3,334	$0.00	$0	9,262
2022-11-18	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	110	$0.00	$0	558
2022-11-18	Neal Shana Carol	EVP and Chief People Officer	Other disposed transaction F	Common Stock	31	$0.00	$0	16,831
2022-11-18	Neal Shana Carol	EVP and Chief People Officer	Exercise / conversion M	Common Stock	110	$0.00	$0	16,862
2022-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	4,617	$0.00	$0	0
2022-11-16	Goette Roland	EVP and President, EMEA	Other disposed transaction D	Common Stock	2,996	$222.08	$665,352	11,900
2022-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	4,617	$74.94	$345,998	14,896
2022-11-11	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	113	$235.97	$26,665	8,881
2022-09-07	DelOrefice Christopher	EVP & CFO	Other disposed transaction F	Common Stock	506	$0.00	$0	9,135
2022-09-01	DelOrefice Christopher	EVP & CFO	Equity grant / award A	Common Stock	2,674	$0.00	$0	9,641
2022-08-15	Hickey David	EVP & President, Life Sciences	Open-market sell S	Common Stock	475	$265.00	$125,875	3,331
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Exercise / conversion M · derivative	Stock Appreciation Rights	12,489	$0.00	$0	0
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Exercise / conversion M · derivative	Stock Appreciation Rights	14,326	$0.00	$0	0
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction D	Common Stock	5,194	$260.44	$1,352,725	13,223
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Exercise / conversion M	Common Stock	12,489	$108.25	$1,351,934	18,417
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Open-market sell S	Common Stock	9,185	$260.44	$2,392,141	5,928
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction D	Common Stock	5,141	$260.44	$1,338,922	15,113
2022-08-09	Khichi Samrat S.	EVP and General Counsel	Exercise / conversion M	Common Stock	14,326	$93.49	$1,339,338	20,254
2022-08-08	Khichi Samrat S.	EVP and General Counsel	Open-market sell S	Common Stock	7,295	$260.44	$1,899,910	5,928
2022-07-29	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	109	$244.31	$26,630	8,768
2022-07-08	Grover Rishi	EVP and Chief ISC Officer	Equity grant / award A	Common Stock	9,340	$0.00	$0	9,439
2022-07-01	Spoerel Thomas J	VP Controller & Chief Acct Off	Equity grant / award A	Common Stock	414	$0.00	$0	1,472
2022-06-17	Lim James C	Executive Vice President	Equity grant / award A	Common Stock	3,280	$0.00	$0	23,941
2022-06-07	Spoerel Thomas J	VP Controller & Chief Acct Off	Exercise / conversion M · derivative	Stock Appreciation Rights	1,026	$0.00	$0	0
2022-06-07	Spoerel Thomas J	VP Controller & Chief Acct Off	Open-market sell S	Common Stock	443	$260.00	$115,180	1,058
2022-06-07	Spoerel Thomas J	VP Controller & Chief Acct Off	Other disposed transaction D	Common Stock	583	$260.00	$151,580	1,487
2022-06-07	Spoerel Thomas J	VP Controller & Chief Acct Off	Exercise / conversion M	Common Stock	1,026	$147.68	$151,520	2,070
2022-05-06	Byington Carrie L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	107	$255.00	$27,285	215
2022-04-06	Neal Shana Carol	Chief Human Resources Officer	Equity grant / award A	Common Stock	7,525	$0.00	$0	7,599
2022-04-01	BECTON DICKINSON & CO	10%	Other disposed transaction J	Common Stock	57,797,725	$0.00	$0	0
2022-03-02	Ezell Antoine C	EVP, President, NA & CMO	Other disposed transaction F	Common Stock	610	$0.00	$0	7,325
2022-03-01	Ezell Antoine C	EVP, President, NA & CMO	Other disposed transaction F	Common Stock	276	$0.00	$0	7,935
2022-02-28	Brown William M	Dir	Equity grant / award A	Common Stock	714	$0.00	$0	714
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	3,684	$0.00	$0	11,052
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	1,244	$0.00	$0	2,490
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	4,630	$0.00	$0	4,630
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	6,789	$0.00	$0	2,265
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	10,245	$0.00	$0	0
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	9,377	$0.00	$0	0
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	7,076	$0.00	$0	0
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	3,613	$0.00	$0	0
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	601	$271.90	$163,412	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	3,083	$271.90	$838,268	6,473
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	3,684	$227.47	$837,999	9,556
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	203	$271.90	$55,196	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	1,041	$271.90	$283,048	6,075
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	1,244	$227.47	$282,973	7,116
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	284	$271.90	$77,220	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	4,346	$271.90	$1,181,677	6,156
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	4,630	$255.22	$1,181,669	10,502
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	744	$271.90	$202,294	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	6,045	$271.90	$1,643,636	6,616
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	6,789	$242.10	$1,643,617	12,661
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	2,036	$271.90	$553,588	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	8,209	$271.90	$2,232,027	7,908
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	10,245	$217.84	$2,231,771	16,117
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	4,442	$271.90	$1,207,780	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	4,935	$271.90	$1,341,826	10,314
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	9,377	$143.07	$1,341,567	15,249
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	3,914	$271.90	$1,064,217	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	3,162	$271.90	$859,748	9,786
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	7,076	$121.49	$859,663	12,948
2022-02-25	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	2,150	$271.90	$584,585	5,872
2022-02-25	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	1,463	$271.90	$397,790	8,022
2022-02-25	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	3,613	$110.04	$397,575	9,485
2022-02-11	Campion Simon D	EVP and Segment President	Equity grant / award G	Common Stock	50	$0.00	$0	10,319
2022-02-08	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	375	$0.00	$0	5,928
2022-02-03	Conroy Alexandre	EVP of Integrated Supply Chain	Exercise / conversion M · derivative	Stock Appreciation Rights	12,787	$0.00	$0	0
2022-02-03	Conroy Alexandre	EVP of Integrated Supply Chain	Open-market sell S	Common Stock	6,410	$270.16	$1,731,726	21,260
2022-02-03	Conroy Alexandre	EVP of Integrated Supply Chain	Other disposed transaction D	Common Stock	6,377	$270.16	$1,722,810	27,670
2022-02-03	Conroy Alexandre	EVP of Integrated Supply Chain	Exercise / conversion M	Common Stock	12,787	$134.73	$1,722,793	34,047
2022-02-02	Byington Carrie L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	105	$253.58	$26,626	105
2022-01-27	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	190	$0.00	$0	10,369
2022-01-25	RING TIMOTHY M	Dir	Equity grant / award A	Common Stock	820	$0.00	$0	77,816
2021-12-16	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	893	$0.00	$0	0
2021-12-16	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	2,789	$255.00	$711,195	5,872
2021-12-16	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	552	$255.00	$140,760	8,661
2021-12-16	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	341	$255.00	$86,955	9,213
2021-12-16	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	893	$97.14	$86,746	9,554
2021-12-07	Spoerel Thomas J	VP Controller & Chief Acct Off	Open-market sell S	Common Stock	233	$250.00	$58,250	1,079
2021-11-26	Polen Thomas E Jr	Executive Vice President	Equity grant / award A · derivative	Stock Appreciation Rights	75,632	$0.00	$0	75,632
2021-11-26	Polen Thomas E Jr	Executive Vice President	Equity grant / award A	Common Stock	10,583	$0.00	$0	28,878
2021-11-26	Polen Thomas E Jr	Executive Vice President	Other disposed transaction F	Common Stock	1,913	$0.00	$0	18,295
2021-11-26	Polen Thomas E Jr	Executive Vice President	Equity grant / award A	Common Stock	2,786	$0.00	$0	20,208
2021-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	3,055	$0.00	$0	0
2021-11-16	Goette Roland	EVP and President, EMEA	Other disposed transaction F	Common Stock	1,914	$244.11	$467,227	9,373
2021-11-16	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	3,055	$72.12	$220,327	11,287
2021-11-02	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	112	$243.11	$27,228	8,093
2021-10-21	Byington Carrie L	Dir	Equity grant / award A	Common Stock	221	$0.00	$0	221
2021-09-08	Spoerel Thomas J	VP Controller & Chief Acct Off	Open-market sell S	Common Stock	267	$260.00	$69,420	1,018
2021-09-07	DelOrefice Christopher	EVP & CFO	Equity grant / award A	Common Stock	4,359	$0.00	$0	4,359
2021-09-04	Hickey David	EVP & President, Life Sciences	Other disposed transaction F	Common Stock	268	$0.00	$0	4,086
2021-09-03	Lim James C	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	14,584	$0.00	$0	0
2021-09-03	Lim James C	Executive Vice President	Open-market sell S	Common Stock	6,956	$257.44	$1,790,753	19,768
2021-09-03	Lim James C	Executive Vice President	Other disposed transaction D	Common Stock	7,628	$257.44	$1,963,752	26,724
2021-09-03	Lim James C	Executive Vice President	Exercise / conversion M	Common Stock	14,584	$134.73	$1,964,902	34,352
2021-09-02	RIMEL REBECCA W	Dir	Open-market sell S	Common Stock	244	$254.00	$61,976	11,618
2021-08-30	RIMEL REBECCA W	Dir	Open-market sell S	Common Stock	207	$252.00	$52,164	11,862
2021-08-18	Fraser Claire	Dir	Open-market sell S	Common Stock	387	$251.58	$97,361	20,220
2021-08-17	RIMEL REBECCA W	Dir	Open-market sell S	Common Stock	207	$252.00	$52,164	12,069
2021-08-06	Spoerel Thomas J	VP Controller & Chief Acct Off	Open-market sell S	Common Stock	266	$242.30	$64,452	1,285
2021-08-03	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	104	$256.38	$26,664	7,927
2021-05-28	Lim James C	Executive Vice President	Open-market sell S	Common Stock	3,429	$241.68	$828,721	801
2021-05-27	Fraser Claire	Dir	Open-market sell S	Common Stock	390	$241.36	$94,130	20,607
2021-05-03	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	107	$253.39	$27,113	7,823
2021-03-02	Ezell Antoine C	EVP, President, NA & CMO	Other disposed transaction F	Common Stock	505	$0.00	$0	4,636
2021-03-01	Ezell Antoine C	EVP, President, NA & CMO	Equity grant / award A	Common Stock	2,817	$0.00	$0	7,453
2021-02-08	Larson Betty D	EVP HR & CHRO	Other disposed transaction F	Common Stock	760	$0.00	$0	6,585
2021-02-02	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	198	$260.53	$51,585	16,138
2021-01-27	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	198	$0.00	$0	9,181
2021-01-26	SCOTT BERTRAM L	Dir	Equity grant / award A	Common Stock	829	$0.00	$0	30,515
2021-01-02	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction F	Common Stock	669	$0.00	$0	5,696
2021-01-02	Khichi Samrat S.	EVP and General Counsel	Equity grant / award A	Common Stock	1,295	$0.00	$0	6,365
2020-12-15	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	268	$0.00	$0	194,048
2020-12-14	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	205	$0.00	$0	9,204
2020-12-10	Campion Simon D	EVP and Segment President	Equity grant / award G	Common Stock	50	$0.00	$0	9,409
2020-11-26	FORLENZA VINCENT A	Chairman of the Board	Other disposed transaction F	Common Stock	7,080	$0.00	$0	194,316
2020-11-26	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award A	Common Stock	7,969	$0.00	$0	201,396
2020-11-26	Campion Simon D	EVP and Segment President	Equity grant / award A · derivative	Stock Appreciation Rights	3,154	$0.00	$0	3,154
2020-11-26	Campion Simon D	EVP and Segment President	Equity grant / award A · derivative	Stock Appreciation Rights	16,023	$0.00	$0	16,023
2020-11-26	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	184	$0.00	$0	9,459
2020-11-23	Goette Roland	EVP and President, EMEA	Exercise / conversion M · derivative	Stock Appreciation Rights	3,485	$0.00	$0	0
2020-11-23	Goette Roland	EVP and President, EMEA	Open-market sell S	Common Stock	930	$230.10	$213,993	7,994
2020-11-23	Goette Roland	EVP and President, EMEA	Other disposed transaction D	Common Stock	1,161	$230.10	$267,146	8,924
2020-11-23	Goette Roland	EVP and President, EMEA	Exercise / conversion M	Common Stock	3,485	$76.64	$267,090	10,085
2020-11-18	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	462	$0.00	$0	193,427
2020-11-12	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	104	$0.00	$0	193,889
2020-11-10	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	7,507	$0.00	$0	193,993
2020-11-04	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	115	$237.66	$27,331	15,887
2020-09-01	Spoerel Thomas J	VP Controller & Chief Acct Off	Other disposed transaction F	Common Stock	59	$0.00	$0	976
2020-08-13	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	57	$261.50	$14,906	15,619
2020-07-14	Kaltenbach Patrick	EVP & Pres Life Sciences	Equity grant / award A · derivative	Rights to Common Stock Under BD Deferred Compensation Plan	620	$263.40	$163,308	620
2020-07-10	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	11,660	$0.00	$0	186,486
2020-07-09	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	1,272	$260.00	$330,720	10,340
2020-06-30	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	21,192	$0.00	$0	198,146
2020-06-05	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	1,049	$243.20	$255,117	11,612
2020-06-03	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction F	Common Stock	2,027	$0.00	$0	12,661
2020-06-02	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	222	$244.83	$54,352	14,688
2020-06-01	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction F	Common Stock	400	$0.00	$0	14,910
2020-05-27	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	106	$234.59	$24,867	7,271
2020-05-13	FORLENZA VINCENT A	Chairman of the Board	Equity grant / award G	Common Stock	10,474	$0.00	$0	219,338
2020-05-08	Fraser Claire	Dir	Open-market sell S	Common Stock	771	$256.56	$197,808	20,168
2020-03-16	Khichi Samrat S.	EVP and General Counsel	Open-market sell S	Common Stock	4,349	$224.53	$976,481	5,262
2020-02-19	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	195	$0.00	$0	9,611
2020-02-14	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	188	$275.18	$51,734	15,456
2020-02-11	Fraser Claire	Dir	Open-market sell S	Common Stock	700	$258.70	$181,090	20,939
2020-02-11	Fraser Claire	Dir	Open-market sell S	Common Stock	800	$258.73	$206,984	21,639
2020-02-10	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction F	Common Stock	2,338	$0.00	$0	9,806
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M · derivative	Stock Appreciation Rights	2,891	$0.00	$0	963
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M · derivative	Stock Appreciation Rights	4,783	$0.00	$0	0
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M · derivative	Stock Appreciation Rights	3,089	$0.00	$0	0
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M · derivative	Stock Appreciation Rights	2,326	$0.00	$0	0
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M · derivative	Stock Appreciation Rights	523	$0.00	$0	0
2020-02-04	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	1,439	$285.09	$410,245	10,773
2020-02-04	Campion Simon D	EVP and Segment President	Other disposed transaction D	Common Stock	1,452	$285.09	$413,951	12,212
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M	Common Stock	2,891	$143.07	$413,615	13,664
2020-02-04	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	2,744	$285.09	$782,287	10,773
2020-02-04	Campion Simon D	EVP and Segment President	Other disposed transaction D	Common Stock	2,039	$285.09	$581,299	13,517
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M	Common Stock	4,783	$121.49	$581,087	15,556
2020-02-04	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	1,896	$285.09	$540,531	10,773
2020-02-04	Campion Simon D	EVP and Segment President	Other disposed transaction D	Common Stock	1,193	$285.09	$340,112	12,669
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M	Common Stock	3,089	$110.04	$339,914	13,862
2020-02-04	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	1,600	$285.09	$456,144	10,773
2020-02-04	Campion Simon D	EVP and Segment President	Other disposed transaction D	Common Stock	726	$285.09	$206,975	12,373
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M	Common Stock	2,326	$88.87	$206,712	13,099
2020-02-04	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	406	$285.09	$115,747	10,773
2020-02-04	Campion Simon D	EVP and Segment President	Other disposed transaction D	Common Stock	117	$285.09	$33,356	11,179
2020-02-04	Campion Simon D	EVP and Segment President	Exercise / conversion M	Common Stock	523	$63.66	$33,294	11,296
2020-01-28	ECKERT R ANDREW	Dir	Equity grant / award A	Common Stock	765	$0.00	$0	4,555
2020-01-27	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	34,406	$0.00	$0	38,362
2020-01-27	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	25,546	$280.09	$7,155,179	208,864
2020-01-27	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	8,860	$280.09	$2,481,597	234,410
2020-01-27	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	34,406	$72.12	$2,481,361	243,270
2020-01-27	Campion Simon D	EVP and Segment President	Equity grant / award A	Common Stock	1,876	$0.00	$0	10,773
2020-01-24	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	9,666	$0.00	$0	72,768
2020-01-24	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	7,177	$280.13	$2,010,493	208,864
2020-01-24	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	2,489	$280.13	$697,244	216,041
2020-01-24	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	9,666	$72.12	$697,112	218,530
2020-01-23	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	8,464	$0.00	$0	82,434
2020-01-23	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	6,284	$280.06	$1,759,897	208,864
2020-01-23	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	2,180	$280.06	$610,531	215,148
2020-01-23	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	8,464	$72.12	$610,424	217,328
2020-01-10	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	26,665	$0.00	$0	90,898
2020-01-10	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	19,675	$275.15	$5,413,576	208,864
2020-01-10	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	6,990	$275.15	$1,923,298	228,539
2020-01-10	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	26,665	$72.12	$1,923,080	235,529
2020-01-08	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	18,783	$0.00	$0	117,563
2020-01-08	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	13,860	$275.19	$3,814,133	208,864
2020-01-08	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	4,923	$275.19	$1,354,760	222,724
2020-01-08	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	18,783	$72.12	$1,354,630	227,647
2020-01-02	Larson Betty D	EVP HR & CHRO	Other disposed transaction F	Common Stock	374	$0.00	$0	8,305
2020-01-01	RING TIMOTHY M	Dir	Other disposed transaction F	Common Stock	7,027	$0.00	$0	74,278
2019-12-19	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	186	$0.00	$0	208,864
2019-12-16	Mas Ribo Alberto	EVP and Pres, Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	12,153	$0.00	$0	0
2019-12-16	Mas Ribo Alberto	EVP and Pres, Life Sciences	Open-market sell S	Common Stock	11,860	$269.51	$3,196,389	9,811
2019-12-16	Mas Ribo Alberto	EVP and Pres, Life Sciences	Other disposed transaction D	Common Stock	6,068	$269.51	$1,635,387	21,671
2019-12-16	Mas Ribo Alberto	EVP and Pres, Life Sciences	Exercise / conversion M	Common Stock	12,153	$134.73	$1,637,374	27,739
2019-12-14	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	133	$0.00	$0	8,955
2019-12-13	Spoerel Thomas J	VP Controller & Chief Acct Off	Open-market sell S	Common Stock	506	$267.95	$135,583	1,035
2019-12-12	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	4,236	$0.00	$0	12,710
2019-12-12	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	339	$263.23	$89,235	15,310
2019-12-12	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction D	Common Stock	3,897	$263.23	$1,025,807	15,649
2019-12-12	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M	Common Stock	4,236	$242.10	$1,025,536	19,546
2019-12-09	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	147	$0.00	$0	9,088
2019-12-06	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	312	$261.51	$81,591	15,310
2019-12-02	Campion Simon D	EVP and Segment President	Equity grant / award G	Common Stock	50	$0.00	$0	9,235
2019-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction F	Common Stock	13,190	$0.00	$0	209,050
2019-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award A	Common Stock	16,742	$0.00	$0	222,240
2019-11-26	Larson Betty D	EVP HR & CHRO	Equity grant / award A · derivative	Stock Appreciation Rights	9,260	$0.00	$0	9,260
2019-11-26	Larson Betty D	EVP HR & CHRO	Other disposed transaction F	Common Stock	164	$0.00	$0	8,679
2019-11-26	Spoerel Thomas J	VP Controller & Chief Acct Off	Equity grant / award A	Common Stock	596	$0.00	$0	1,541
2019-11-13	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	104	$256.00	$26,624	15,268
2019-10-21	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	15,590	$0.00	$0	205,498
2019-09-06	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	16,343	$0.00	$0	16,343
2019-09-06	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	11,532	$260.38	$3,002,702	221,088
2019-09-06	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	4,811	$260.38	$1,252,688	232,620
2019-09-06	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	16,343	$76.64	$1,252,528	237,431
2019-09-06	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	13,760	$0.00	$0	13,763
2019-09-06	Polen Thomas E Jr	Executive Vice President	Open-market sell S	Common Stock	5,823	$260.26	$1,515,494	16,455
2019-09-06	Polen Thomas E Jr	Executive Vice President	Other disposed transaction D	Common Stock	7,937	$260.26	$2,065,684	22,778
2019-09-06	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M	Common Stock	13,760	$150.12	$2,065,651	30,215
2019-09-05	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	59	$0.00	$0	12,549
2019-08-30	Conroy Alexandre	EVP of Integrated Supply Chain	Open-market sell S	Common Stock	46	$256.72	$11,809	16,489
2019-08-29	Conroy Alexandre	EVP of Integrated Supply Chain	Open-market sell S	Common Stock	9,829	$255.06	$2,506,985	16,535
2019-08-23	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	6,443	$0.00	$0	221,088
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	22,709	$0.00	$0	0
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	8,402	$0.00	$0	0
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	2,855	$0.00	$0	0
2019-08-09	Lim James C	Executive Vice President	Open-market sell S	Common Stock	15,879	$253.31	$4,022,309	17,193
2019-08-09	Lim James C	Executive Vice President	Other disposed transaction D	Common Stock	6,830	$253.31	$1,730,107	33,072
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M	Common Stock	22,709	$76.18	$1,729,972	39,902
2019-08-09	Lim James C	Executive Vice President	Open-market sell S	Common Stock	6,009	$253.31	$1,522,140	17,193
2019-08-09	Lim James C	Executive Vice President	Other disposed transaction D	Common Stock	2,393	$253.31	$606,171	23,202
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M	Common Stock	8,402	$72.12	$605,952	25,595
2019-08-09	Lim James C	Executive Vice President	Open-market sell S	Common Stock	1,991	$253.31	$504,340	17,193
2019-08-09	Lim James C	Executive Vice President	Other disposed transaction D	Common Stock	864	$253.31	$218,860	19,184
2019-08-09	Lim James C	Executive Vice President	Exercise / conversion M	Common Stock	2,855	$76.64	$218,807	20,048
2019-08-08	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	2,865	$0.00	$0	17,193
2019-08-08	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	150	$246.53	$36,980	16,057
2019-08-08	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	250	$246.56	$61,640	16,207
2019-08-08	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction D	Common Stock	2,615	$246.56	$644,754	16,457
2019-08-08	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M	Common Stock	2,865	$224.94	$644,453	19,072
2019-08-07	Fraser Claire	Dir	Open-market sell S	Common Stock	1,429	$243.26	$347,619	21,544
2019-06-24	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	4,026	$0.00	$0	214,645
2019-06-12	Campion Simon D	EVP and Segment President	Open-market sell S	Common Stock	2,903	$236.94	$687,837	9,408
2019-06-10	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	2,865	$0.00	$0	20,058
2019-06-10	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	191	$241.03	$46,037	16,207
2019-06-10	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction D	Common Stock	2,674	$241.03	$644,514	16,398
2019-06-10	Kaltenbach Patrick	EVP & Pres Life Sciences	Exercise / conversion M	Common Stock	2,865	$224.94	$644,453	19,072
2019-06-04	Kaltenbach Patrick	EVP & Pres Life Sciences	Open-market sell S	Common Stock	275	$235.00	$64,625	16,207
2019-06-03	Kaltenbach Patrick	EVP & Pres Life Sciences	Equity grant / award A	Common Stock	12,379	$0.00	$0	16,482
2019-06-01	Kaltenbach Patrick	EVP & Pres Life Sciences	Other disposed transaction F	Common Stock	292	$0.00	$0	4,103
2019-05-21	Khichi Samrat S.	EVP and General Counsel	Open-market sell S	Common Stock	16,085	$234.68	$3,774,828	12,608
2019-05-13	Larson Betty D	EVP HR & CHRO	Exercise / conversion M · derivative	Stock Appreciation Rights	2,200	$0.00	$0	893
2019-05-13	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	450	$224.91	$101,210	8,843
2019-05-13	Larson Betty D	EVP HR & CHRO	Open-market sell S	Common Stock	1,250	$224.99	$281,238	9,293
2019-05-13	Larson Betty D	EVP HR & CHRO	Other disposed transaction D	Common Stock	950	$224.99	$213,740	10,543
2019-05-13	Larson Betty D	EVP HR & CHRO	Exercise / conversion M	Common Stock	2,200	$97.14	$213,708	11,493
2019-05-10	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	111	$240.74	$26,722	15,058
2019-04-17	BURZIK CATHERINE M	Dir	Open-market sell S	Common Stock	45	$223.04	$10,037	10,007
2019-04-16	BURZIK CATHERINE M	Dir	Open-market buy P	Common Stock	30	$247.96	$7,439	10,052
2019-04-16	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	7,764	$0.00	$0	218,671
2019-03-15	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	11,878	$0.00	$0	32,686
2019-03-15	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	8,309	$255.13	$2,119,875	210,907
2019-03-15	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	3,469	$255.13	$885,046	219,216
2019-03-15	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	11,878	$76.64	$910,330	222,785
2019-03-04	Mas Ribo Alberto	EVP and Pres, Life Sciences	Exercise / conversion M · derivative	Stock Appreciation Rights	4,864	$0.00	$0	3,483
2019-03-04	Mas Ribo Alberto	EVP and Pres, Life Sciences	Open-market sell S	Common Stock	2,021	$255.03	$515,416	15,591
2019-03-04	Mas Ribo Alberto	EVP and Pres, Life Sciences	Open-market sell S	Common Stock	2,787	$255.03	$710,769	17,612
2019-03-04	Mas Ribo Alberto	EVP and Pres, Life Sciences	Other disposed transaction D	Common Stock	2,077	$255.03	$529,697	20,399
2019-03-04	Mas Ribo Alberto	EVP and Pres, Life Sciences	Exercise / conversion M	Common Stock	4,864	$108.89	$529,641	22,476
2019-02-25	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	16,343	$0.00	$0	49,029
2019-02-25	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	11,340	$250.40	$2,839,536	210,907
2019-02-25	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	5,003	$250.40	$1,252,751	222,247
2019-02-25	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	16,343	$76.64	$1,252,528	227,250
2019-02-15	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	107	$246.58	$26,384	594
2019-02-11	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction F	Common Stock	3,539	$0.00	$0	28,681
2019-01-22	SCOTT BERTRAM L	Dir	Equity grant / award A	Common Stock	923	$0.00	$0	28,248
2019-01-22	BURZIK CATHERINE M	Dir	Equity grant / award A	Common Stock	923	$0.00	$0	8,324
2019-01-04	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	69	$0.00	$0	32,220
2019-01-02	Khichi Samrat S.	EVP and General Counsel	Other disposed transaction F	Common Stock	216	$0.00	$0	32,289
2019-01-01	RING TIMOTHY M	Dir	Other disposed transaction F	Common Stock	13,306	$0.00	$0	80,382
2018-12-14	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	134	$0.00	$0	13,059
2018-12-11	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	1,260	$0.00	$0	210,907
2018-12-10	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	133	$0.00	$0	13,193
2018-12-09	Campion Simon D	EVP and Segment President	Other disposed transaction F	Common Stock	147	$0.00	$0	13,326
2018-12-04	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	100	$0.00	$0	212,167
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M · derivative	Stock Appreciation Rights	2,938	$0.00	$0	2,941
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M · derivative	Stock Appreciation Rights	6,054	$0.00	$0	2,020
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M · derivative	Stock Appreciation Rights	1,413	$0.00	$0	0
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	1,825	$252.32	$460,484	2,775
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	951	$252.39	$240,023	4,600
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Other disposed transaction D	Common Stock	1,987	$252.39	$501,499	5,551
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M	Common Stock	2,938	$170.69	$501,487	7,538
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	2,453	$252.39	$619,113	4,600
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Other disposed transaction D	Common Stock	3,601	$252.39	$908,856	7,053
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M	Common Stock	6,054	$150.12	$908,826	10,654
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	658	$252.39	$166,073	4,600
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Other disposed transaction D	Common Stock	755	$252.39	$190,554	5,258
2018-11-30	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M	Common Stock	1,413	$134.73	$190,373	6,013
2018-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award A · derivative	Stock Appreciation Rights	92,502	$0.00	$0	92,502
2018-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award A	Common Stock	10,161	$0.00	$0	212,901
2018-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction F	Common Stock	19,243	$0.00	$0	202,740
2018-11-26	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award A	Common Stock	28,203	$0.00	$0	221,983
2018-11-20	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	104	$0.00	$0	212,797
2018-11-19	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	11,718	$0.00	$0	3,907
2018-11-19	Polen Thomas E Jr	Executive Vice President	Open-market sell S	Common Stock	5,243	$243.86	$1,278,558	12,178
2018-11-19	Polen Thomas E Jr	Executive Vice President	Other disposed transaction D	Common Stock	6,475	$243.86	$1,578,994	17,421
2018-11-19	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M	Common Stock	11,718	$134.73	$1,578,766	23,896
2018-11-16	Bodner Charles R	SVP Corp Fin Chief Acct Office	Exercise / conversion M · derivative	Stock Appreciation Rights	2,500	$0.00	$0	3,143
2018-11-16	Bodner Charles R	SVP Corp Fin Chief Acct Office	Open-market sell S	Common Stock	950	$245.82	$233,529	1,047
2018-11-16	Bodner Charles R	SVP Corp Fin Chief Acct Office	Open-market sell S	Common Stock	1,130	$245.84	$277,799	1,997
2018-11-16	Bodner Charles R	SVP Corp Fin Chief Acct Office	Other disposed transaction D	Common Stock	1,370	$245.84	$336,801	3,127
2018-11-16	Bodner Charles R	SVP Corp Fin Chief Acct Office	Exercise / conversion M	Common Stock	2,500	$134.73	$336,825	4,497
2018-11-15	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	530	$0.00	$0	193,780
2018-11-15	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	530	$0.00	$0	212,267
2018-11-14	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	20,000	$0.00	$0	65,372
2018-11-14	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	13,498	$235.78	$3,182,558	194,310
2018-11-14	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	6,502	$235.78	$1,533,042	222,381
2018-11-14	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	20,000	$76.64	$1,532,800	228,883
2018-11-13	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M · derivative	Stock Appreciation Rights	24,742	$0.00	$0	0
2018-11-13	FORLENZA VINCENT A	Chairman, CEO and President	Open-market sell S	Common Stock	16,866	$237.61	$4,007,530	208,883
2018-11-13	FORLENZA VINCENT A	Chairman, CEO and President	Other disposed transaction D	Common Stock	7,876	$237.61	$1,871,416	225,749
2018-11-13	FORLENZA VINCENT A	Chairman, CEO and President	Exercise / conversion M	Common Stock	24,742	$75.63	$1,871,237	233,625
2018-11-08	Lim James C	Executive Vice President	Open-market sell S	Common Stock	5,189	$242.36	$1,257,606	13,318
2018-11-07	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	42,000	$237.07	$9,956,940	93,688
2018-11-06	SCOTT BERTRAM L	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	116	$230.50	$26,738	14,567
2018-08-16	Khichi Samrat S.	EVP and General Counsel	Equity grant / award G	Common Stock	48	$0.00	$0	31,337
2018-08-03	Jones Christopher Ian Montague	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	107	$250.37	$26,790	6,321
2018-07-02	TOZZI WILLIAM A	EVP Pres Interventional	Equity grant / award A	Common Stock	4,008	$0.00	$0	12,830
2018-06-22	BURZIK CATHERINE M	Dir	Open-market buy P	Common Stock	45	$239.01	$10,755	10,022
2018-06-01	Kaltenbach Patrick	EVP & Pres Life Sciences	Equity grant / award A · derivative	Stock Appreciation Rights	22,923	$0.00	$0	22,923
2018-06-01	Kaltenbach Patrick	EVP & Pres Life Sciences	Equity grant / award A	Common Stock	2,533	$0.00	$0	2,533
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	9,000	$0.00	$0	23,441
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	11,763	$0.00	$0	0
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	9,147	$0.00	$0	0
2018-05-21	Conroy Alexandre	Executive Vice President	Open-market sell S	Common Stock	5,999	$228.74	$1,372,211	26,436
2018-05-21	Conroy Alexandre	Executive Vice President	Other disposed transaction D	Common Stock	3,001	$228.74	$686,449	32,435
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M	Common Stock	9,000	$76.18	$685,620	35,436
2018-05-21	Conroy Alexandre	Executive Vice President	Open-market sell S	Common Stock	8,050	$228.74	$1,841,357	26,436
2018-05-21	Conroy Alexandre	Executive Vice President	Other disposed transaction D	Common Stock	3,713	$228.74	$849,312	34,486
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M	Common Stock	11,763	$72.12	$848,348	38,199
2018-05-21	Conroy Alexandre	Executive Vice President	Open-market sell S	Common Stock	6,079	$228.74	$1,390,510	26,436
2018-05-21	Conroy Alexandre	Executive Vice President	Other disposed transaction D	Common Stock	3,068	$228.74	$701,774	32,515
2018-05-21	Conroy Alexandre	Executive Vice President	Exercise / conversion M	Common Stock	9,147	$76.64	$701,026	35,583
2018-05-16	OVERLOCK WILARD J JR	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	115	$224.22	$25,785	24,106
2018-05-11	Shabshab Nabil	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	13,735	$0.00	$0	0
2018-05-11	Shabshab Nabil	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	4,665	$0.00	$0	0
2018-05-11	Shabshab Nabil	Executive Vice President	Open-market sell S	Common Stock	7,117	$226.10	$1,609,154	7,811
2018-05-11	Shabshab Nabil	Executive Vice President	Other disposed transaction D	Common Stock	6,618	$226.10	$1,496,330	14,928
2018-05-11	Shabshab Nabil	Executive Vice President	Exercise / conversion M	Common Stock	13,735	$108.89	$1,495,604	21,546
2018-05-11	Shabshab Nabil	Executive Vice President	Open-market sell S	Common Stock	3,092	$226.10	$699,101	7,811
2018-05-11	Shabshab Nabil	Executive Vice President	Other disposed transaction D	Common Stock	1,573	$226.10	$355,655	10,903
2018-05-11	Shabshab Nabil	Executive Vice President	Exercise / conversion M	Common Stock	4,665	$76.18	$355,380	12,476
2018-05-07	Melcher David F	Dir	Open-market buy P	Common Stock	500	$225.07	$112,535	2,728
2018-04-13	BURZIK CATHERINE M	Dir	Open-market buy P	Common Stock	285	$225.89	$64,379	9,977
2018-03-13	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	2,775	$0.00	$0	0
2018-03-13	Polen Thomas E Jr	Executive Vice President	Open-market sell S	Common Stock	434	$227.00	$98,518	12,178
2018-03-13	Polen Thomas E Jr	Executive Vice President	Open-market sell S	Common Stock	1,443	$227.00	$327,561	12,612
2018-03-13	Polen Thomas E Jr	Executive Vice President	Other disposed transaction D	Common Stock	1,332	$227.00	$302,364	14,055
2018-03-13	Polen Thomas E Jr	Executive Vice President	Exercise / conversion M	Common Stock	2,775	$108.89	$302,170	15,387
2018-03-02	Gallagher John E	VP, Corp Finance and Treasurer	Other disposed transaction F	Common Stock	124	$217.65	$26,989	1,975
2018-02-28	Gallagher John E	VP, Corp Finance and Treasurer	Open-market sell S	Common Stock	9	$226.30	$2,037	2,099
2018-02-27	Gallagher John E	VP, Corp Finance and Treasurer	Exercise / conversion M · derivative	Stock Appreciation Rights	5,746	$0.00	$0	0
2018-02-27	Gallagher John E	VP, Corp Finance and Treasurer	Open-market sell S	Common Stock	1,546	$226.08	$349,520	2,108
2018-02-27	Gallagher John E	VP, Corp Finance and Treasurer	Open-market sell S	Common Stock	3,800	$226.08	$859,104	3,654
2018-02-27	Gallagher John E	VP, Corp Finance and Treasurer	Other disposed transaction D	Common Stock	1,937	$226.08	$437,917	7,454
2018-02-27	Gallagher John E	VP, Corp Finance and Treasurer	Exercise / conversion M	Common Stock	5,746	$76.18	$437,730	9,391
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M · derivative	Stock Appreciation Rights	4,230	$0.00	$0	1,413
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M · derivative	Stock Appreciation Rights	1,508	$0.00	$0	0
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	1,573	$225.00	$353,925	2,253
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	1,697	$224.97	$381,774	3,826
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Other disposed transaction D	Common Stock	2,533	$224.97	$569,849	5,523
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M	Common Stock	4,230	$224.97	$951,623	8,056
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Open-market sell S	Common Stock	778	$224.97	$175,027	3,826
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Other disposed transaction D	Common Stock	730	$224.97	$164,228	4,604
2018-02-26	Borzi James W	EVP & Chief Supply Chain Offcr	Exercise / conversion M	Common Stock	1,508	$224.97	$339,255	5,334
2018-02-23	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	176	$218.27	$38,416	231
2018-02-09	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Rights to Common Stock Under 1996 Directors Deferral Plan	37	$242.94	$8,989	37
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Appreciation Rights	78,155	$0.00	$0	0
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Appreciation Rights	101,064	$0.00	$0	0
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Appreciation Rights	93,946	$0.00	$0	0
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Appreciation Rights	100,339	$0.00	$0	0
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Appreciation Rights	113,644	$0.00	$0	0
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	11,421	$217.82	$2,487,722	170,688
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	26,912	$217.82	$5,861,972	182,109
2018-02-08	RING TIMOTHY M	Dir	Other disposed transaction D	Common Stock	51,243	$217.82	$11,161,750	209,021
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	78,155	$143.07	$11,181,636	260,264
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	44,795	$217.82	$9,757,247	182,109
2018-02-08	RING TIMOTHY M	Dir	Other disposed transaction D	Common Stock	56,269	$217.82	$12,256,514	226,904
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	101,064	$121.49	$12,278,265	283,173
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	46,570	$217.82	$10,143,877	182,109
2018-02-08	RING TIMOTHY M	Dir	Other disposed transaction D	Common Stock	47,376	$217.82	$10,319,440	228,679
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	93,946	$110.04	$10,337,818	276,055
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	59,474	$217.82	$12,954,627	182,109
2018-02-08	RING TIMOTHY M	Dir	Other disposed transaction D	Common Stock	40,865	$217.82	$8,901,214	241,583
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	100,339	$88.87	$8,917,127	282,448
2018-02-08	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	80,489	$217.82	$17,532,114	182,109
2018-02-08	RING TIMOTHY M	Dir	Other disposed transaction D	Common Stock	33,155	$217.82	$7,221,822	262,598
2018-02-08	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	113,644	$63.66	$7,234,577	295,753
2018-02-01	Tharby Linda M	Executive Vice President	Exercise / conversion M · derivative	Rights to Common Stock Under the Deferred Compensation Plan	180	—	—	782
2018-02-01	Tharby Linda M	Executive Vice President	Exercise / conversion M	Common Stock	180	—	—	13,437
2018-01-23	BURZIK CATHERINE M	Dir	Equity grant / award A	Common Stock	941	$0.00	$0	7,259
2018-01-04	OVERLOCK WILARD J JR	Dir	Equity grant / award G	Common Stock	4,000	$0.00	$0	19,442
2018-01-02	Groetelaars John P	EVP	Equity grant / award A · derivative	Stock Appreciation Rights	20,045	$0.00	$0	20,045
2018-01-02	Groetelaars John P	EVP	Equity grant / award A	Common Stock	6,157	$0.00	$0	42,508
2017-12-29	RING TIMOTHY M	Dir	Equity grant / award A	Common Stock	65	$0.00	$0	181,168
2017-11-26	Reidy Christopher R	CFO and EVP of Administration	Equity grant / award A · derivative	Stock Appreciation Rights	28,559	$0.00	$0	28,559
2017-11-26	Reidy Christopher R	CFO and EVP of Administration	Equity grant / award A	Common Stock	2,979	$0.00	$0	21,397
2017-11-26	Borzi James W	EVP & Chief Supply Chain Offcr	Equity grant / award A	Common Stock	715	$0.00	$0	3,826
2017-11-25	Reidy Christopher R	CFO and EVP of Administration	Other disposed transaction F	Common Stock	6,767	$0.00	$0	18,418
2017-11-25	Reidy Christopher R	CFO and EVP of Administration	Equity grant / award A	Common Stock	8,411	$0.00	$0	25,185
2017-11-03	Tharby Linda M	Executive Vice President	Other acquired transaction I · derivative	Rights to Common Stock Under the Deferred Compensation Plan	962	$224.41	$215,882	962
2017-09-11	COHEN GARY M	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	24,011	$0.00	$0	0
2017-09-11	COHEN GARY M	Executive Vice President	Open-market sell S	Common Stock	15,512	$203.77	$3,160,880	71,770
2017-09-11	COHEN GARY M	Executive Vice President	Other disposed transaction D	Common Stock	8,499	$203.77	$1,731,841	87,282
2017-09-11	COHEN GARY M	Executive Vice President	Exercise / conversion M	Common Stock	24,011	$72.12	$1,731,673	95,781
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	3,670	$0.00	$0	11,010
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	6,184	$0.00	$0	6,186
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	11,094	$0.00	$0	3,698
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	6,085	$0.00	$0	0
2017-09-08	Sichak Stephen	Executive Vice President	Open-market sell S	Common Stock	921	$200.46	$184,624	7,953
2017-09-08	Sichak Stephen	Executive Vice President	Other disposed transaction D	Common Stock	2,749	$200.46	$551,065	8,874
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M	Common Stock	3,670	$150.12	$550,940	11,623
2017-09-08	Sichak Stephen	Executive Vice President	Open-market sell S	Common Stock	2,027	$200.46	$406,332	7,953
2017-09-08	Sichak Stephen	Executive Vice President	Other disposed transaction D	Common Stock	4,157	$200.46	$833,312	9,980
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M	Common Stock	6,184	$134.73	$833,170	14,137
2017-09-08	Sichak Stephen	Executive Vice President	Open-market sell S	Common Stock	5,067	$200.46	$1,015,731	7,953
2017-09-08	Sichak Stephen	Executive Vice President	Other disposed transaction D	Common Stock	6,027	$200.46	$1,208,172	13,020
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M	Common Stock	11,094	$108.89	$1,208,026	19,047
2017-09-08	Sichak Stephen	Executive Vice President	Open-market sell S	Common Stock	3,772	$200.46	$756,135	7,953
2017-09-08	Sichak Stephen	Executive Vice President	Other disposed transaction D	Common Stock	2,313	$200.46	$463,664	11,725
2017-09-08	Sichak Stephen	Executive Vice President	Exercise / conversion M	Common Stock	6,085	$76.18	$463,555	14,038
2017-08-22	Tharby Linda M	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	7,333	$0.00	$0	7,333
2017-08-22	Tharby Linda M	Executive Vice President	Open-market sell S	Common Stock	4,695	$200.48	$941,254	11,337
2017-08-22	Tharby Linda M	Executive Vice President	Other disposed transaction D	Common Stock	2,638	$200.48	$528,866	16,032
2017-08-22	Tharby Linda M	Executive Vice President	Exercise / conversion M	Common Stock	7,333	$72.12	$528,856	18,670
2017-08-15	Shabshab Nabil	Executive Vice President	Open-market sell S	Common Stock	2,865	$202.37	$579,790	5,839
2017-08-14	Shabshab Nabil	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	3,899	$0.00	$0	11,699
2017-08-14	Shabshab Nabil	Executive Vice President	Exercise / conversion M · derivative	Stock Appreciation Rights	6,944	$0.00	$0	6,945
2017-08-14	Shabshab Nabil	Executive Vice President	Open-market sell S	Common Stock	990	$201.22	$199,208	8,704
2017-08-14	Shabshab Nabil	Executive Vice President	Other disposed transaction D	Common Stock	2,909	$201.22	$585,349	9,694
2017-08-14	Shabshab Nabil	Executive Vice President	Exercise / conversion M	Common Stock	3,899	$150.12	$585,318	12,603
2017-08-14	Shabshab Nabil	Executive Vice President	Open-market sell S	Common Stock	2,294	$201.22	$461,599	8,704
2017-08-14	Shabshab Nabil	Executive Vice President	Other disposed transaction D	Common Stock	4,650	$201.22	$935,673	10,998
2017-08-14	Shabshab Nabil	Executive Vice President	Exercise / conversion M	Common Stock	6,944	$134.73	$935,565	15,648
2017-08-10	FORLENZA VINCENT A	Chairman, CEO and President	Equity grant / award G	Common Stock	1,123	$0.00	$0	208,883
2017-05-18	OVERLOCK WILARD J JR	Dir	Equity grant / award G	Common Stock	5,500	$0.00	$0	23,442

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count